SurGenTec® Enters Exclusive License Agreement with Allevion Medical for Vantage™ Spinal Decompression System

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a privately held medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that it has entered into an exclusive license agreement with Allevion Medical for its patented Vantage™ spinal decompression technology.

Under the terms of the agreement, SurGenTec® has secured exclusive rights to Allevion Medical's Vantage™, a fully disposable, sterile system designed to simplify and enhance minimally invasive lumbar decompression procedures. The system addresses pain associated with hypertrophic bone growth, a common contributor to lumbar spinal stenosis. Vantage™ allows physicians to perform a laminotomy or laminectomy through a patented minimally invasive approach while directly visualizing anatomical structures.

Vantage™ enables targeted decompression through a patented approach that combines precision with procedural control. It follows an intuitive, reproducible workflow (locate, visualize, decompress) that helps physicians perform the procedure with greater consistency and efficiency. This structured approach supports procedural safety while enabling surgeons to efficiently remove hypertrophic bone from the lamina and facet joints that may contribute to spinal canal narrowing.

Traditional decompression procedures often require larger incisions and bulky instrumentation to retract tissue, which may increase the risk of scar tissue formation, prolonged recovery, and chronic pain. Other minimally invasive systems focus primarily on soft tissue removal, such as the ligamentum flavum alone, which may not provide sufficient decompression when hypertrophic bone is a primary contributor to stenosis.

A key differentiator of Vantage™ is its direct visualization capability, supported by single-use integrated illumination that allows physicians to visualize the targeted anatomy throughout the procedure. This feature enhances procedural control while supporting greater precision and safety.

Key highlights of Vantage™ include:

• Fully disposable, sterile system requiring no additional instruments or sterile processing
• Reproducible, step-based workflow designed to support procedural safety and efficiency
• Minimally invasive approach designed to limit tissue disruption
• Precision tools engineered for depth-controlled bone resection
• Single-use integrated illumination enabling direct visualization of the surgical site
• Protective guards designed to help reduce the risk of damage to delicate structures

Vantage™ provides physicians with a streamlined and reliable solution for treating lumbar spinal stenosis. Its single-use design, structured workflow, and integrated visualization capabilities help establish a new standard for efficiency, control, and consistency in spinal decompression procedures.

"This exclusive license agreement expands SurGenTec®'s portfolio of innovative, minimally invasive spine solutions and aligns with our commitment to delivering advanced technologies that improve procedural efficiency and patient outcomes," said Matt Marta, VP of Sales at SurGenTec®. "Vantage™ complements our existing offerings by providing surgeons with a fully disposable system designed for precision and ease of use in treating lumbar spinal stenosis."

About SurGenTec®

SurGenTec® is a privately held medical device company based in Boca Raton, Florida, specializing in innovative technologies for orthopedic and spine treatments. The company develops and manufactures solutions focused on minimally invasive approaches, including facet fixation systems, synthetic biologics, bone graft delivery systems, and sacroiliac joint fusion technologies. SurGenTec® is dedicated to advancing patient care through continuous innovation and is expanding its presence in both domestic and international markets. For more information, visit www.surgentec.com/vantage.